Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1β, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

被引:0
|
作者
El-Shabrawi, Y [1 ]
Christen, WG [1 ]
Foster, CS [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Immunol & Uveitis Serv, Boston, MA 02114 USA
关键词
uveitis; matrix metalloproteinases; interleukin-1; beta; interleukin-1 receptor antagonists; interleukin-12; proinflammatory cytokines; human;
D O I
10.1076/0271-3683(200003)20:3;1-9;FT211
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Matrix metalloproteinases have been shown to play a role in active uveitis. Transcription of MMPs is induced by a number of growth factors and cytokines. This study investigates the role of MMPs in chronic uveitis and correlates the amounts of MMP-2 and -9 in intraocular samples to the intraocular levels of proinflammatory cytokines (Interleukin-1 [IL-1], Interleukin-12 [IL-12] and Interleukin-1 receptor antagonist [IL-1ra]). Methods. Aqueous humor of 16 patients was collected during surgical or diagnostic procedures (control group: cataract patients). MMP-2 and -9 were measured using zymography. IL-1, IL-12 and IL-1ra were evaluated by ELISA. Results. We found MMP-2 and -9 in all of our uveitis patients. In the control group only MMP-2 was seen. Higher levels of MMP-2 and -9 were found in patients with higher activity of uveitis (p < 0.014 for MMP-2, p < 0.0054 for MMP-9). The amounts of IL-1, IL-12 and IL-1ra detected in our uveitis patients correlated with levels of MMP-2 (p < 0.07, p < 0.0004, p < 0.03) and MMP-9 (p < 0.003, p < 0.0001, p < 0.002), and IL-12 (p < 0.004, p < 0.0001). Patients with moderately active uveitis presented with twice the level of MMP-2 as the control group; MMP-9 levels reached up to 92% of the amounts found in patients with active uveitis. Two patients in remission for almost one year still had detectable intraocular MMP-9 levels. Conclusion. Our data suggests that the high levels of MMPs found in patients with chronic uveitis might contribute to the damage often seen in these eyes. Since MMPs are capable of releasing proinflammatory cytokines bound to components of the extracellular matrix, and facilitate the secretion of active TNF-alpha by cleavage of the membrane bound form, it is conceivable that MMPs contribute to the chronicity of some uveitis cases.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 50 条
  • [1] Amount of interleukin-1β and interleukin-1 receptor antagonist in periodontitis and healthy patients
    Gilowski, Lukasz
    Wiench, Rafal
    Plocica, Iwona
    Krzeminski, Tadeusz Faustyn
    ARCHIVES OF ORAL BIOLOGY, 2014, 59 (07) : 729 - 734
  • [2] Cytokines and periodontitis. Part I: interleukin-1 and interleukin-1 receptor antagonist
    Slotwinska, Sylwia Malgorzata
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 37 (02) : 173 - 177
  • [3] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    Journal of Clinical Immunology, 1997, 17 : 253 - 261
  • [4] INTERLEUKIN-1 AND OTHER PROINFLAMMATORY CYTOKINES
    MIOSSEC, P
    PEDIATRIE, 1991, 46 (02): : 135 - 139
  • [5] Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
    Cannon, JG
    Angel, JB
    Abad, LW
    Vannier, E
    Mileno, MD
    Fagioli, L
    Wolff, SM
    Komaroff, AL
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 253 - 261
  • [6] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis
    van der Paardt, M
    Crusius, JBA
    García-González, MA
    Baudoin, P
    Kostense, PJ
    Alizadeh, BZ
    Dijkmans, BAC
    Peña, AS
    van der Horst-Bruinsma, IE
    RHEUMATOLOGY, 2002, 41 (12) : 1419 - 1423
  • [7] Plasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia
    Kimya, Y
    Akdis, C
    Cengiz, C
    Ozan, H
    Tatlikazan, S
    Uncu, G
    Sengul, F
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 73 (01): : 17 - 21
  • [8] Interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist share a common U-shaped recognition epitope on interleukin-1 receptor surface
    Ma, Huaijun
    Liu, Jie
    Wu, Wei
    He, Ping
    JOURNAL OF MOLECULAR RECOGNITION, 2022, 35 (09)
  • [9] INTERLEUKIN-1 RECEPTOR ANTAGONIST - EFFECTIVENESS AGAINST INTERLEUKIN-1 FEVER
    COCEANI, F
    LEES, J
    REDFORD, J
    BISHAI, I
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (12) : 1590 - 1596
  • [10] INTERLEUKIN-1 RECEPTOR ANTAGONIST
    LACHAUX, A
    PEDIATRIE, 1991, 46 (10): : 657 - 661